CDC73 and parathyroid gland carcinoma: When pathologists discuss parafibromin, it is typically in the context of diagnosing an atypical parathyroid tumor or parathyroid carcinoma, as these conditions are more frequently associated with CDC73 gene mutations compared to parathyroid adenomas [2, 3].